Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Brief Commentary
Case Report
Case Series
Conference Review
Consensus Statement
Current Issue
Editorial
Erratum
Letter to Editor
New Drug Update
News
Original Article
Position Paper
Response to the letter
Review Article
Short Communication

Most Viewed Articles


Articles Fulltext downloads PDF downloads
Short Communication
Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI:10.25259/IJMIO_30_2020
8,956 1,074
Editorial
Nanobytes
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_7_2019
4,767 4,029
Review Article
The evolving role of precision medicine in the management of advanced sarcomas – A mini review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_6_2021
8,575 75
New Drug Update
Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_13_2021
8,470 75
Case Report
Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_16_2021
8,468 62
Brief Commentary
ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_10_2021
8,148 39
Review Article
Immuno-oncology of differentiated thyroid cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI:10.25259/IJMIO_36_2020
7,142 1,001
Review Article
Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_12_2021
7,889 77
Review Article
A compendium of population wide DNA methylation profile for oral cancer in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI:10.25259/IJMIO_2_2021
6,879 1,079
Brief Commentary
Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_7_2021
6,921 210
Editorial
Misleading and Biased Lancet Editorial on Kashmir: What are the Authors Hiding?
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_8_2019
3,143 3,880
Original Article
Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_1_2019
3,157 3,426
Original Article
Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation region
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI:10.25259/IJMIO_15_2021
5,684 689
Position Paper
Practical consensus recommendations – Current role of immune response evaluation criteria in solid tumors criteria in the management of cancer patients receiving immunotherapy
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
DOI:10.25259/IJMIO-6-2019
3,741 2,485
Original Article
Indian Surgeons’ Perspective Regarding Breast-Conserving Surgery: A Cohort Study
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_15_2019
2,884 3,254
Short Communication
Driver mutations in oncogenesis
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI:10.25259/IJMIO_26_2020
5,640 460
News
Editorial board tribute to Dr. Amit Verma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
5,957 52
Brief Commentary
Myths in oncology
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI:10.25259/IJMIO_37_2020
4,825 1,117
Editorial
Nanobytes
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI:10.25259/IJMIO_11_2021
5,265 667
Case Report
Metastatic endometrial carcinoma responsive to pembrolizumab
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI:10.25259/IJMIO_18_2020
4,058 1,865
Conference Review
6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI:10.25259/IJMIO_20_2021
5,823 57
Editorial
Immune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun!
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI:10.25259/IJMIO_23_2019
3,120 2,732
Original Article
Multiple gene silencing in pathway in K562 cells
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
DOI:10.25259/IJMIO-5-2019
3,441 2,392
Case Report
Complete metabolic response with letrozole and palbociclib in advanced breast cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI:10.25259/IJMIO_2_2019
3,515 2,250
Review Article
Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent hybridization and Immunohistochemistry: A meta-analysis with systematic review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI:10.25259/IJMIO_17_2019
2,866 2,645